Attorney Docket No. 12080027.000019
PATENT
IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
IN RE Application of;
Application No.:
Filed:
RUSSELL A. HOUSER
10/825,786
April 16, 2004
For: METHOD AND DEVICES FOR TREATING
ISCHEMIC CONGESTIVE HEART
FAILURE
Examiner:
□OWE
Art Unit:
Katherine Marie
3734
INFORMATION DISCLOSURE STATEMENT (IDS)
Mail Stop After Final
Commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450
Sir:
Pursuant to 37 CFR 1.56, 1.97 and 1 .98, the attention of the Patent and Trademark
Office is hereby directed to the references listed on the attached Form PTO/SB/08. it is
respectfully requested that the information be expressly considered during the prosecution
of this application, and that the references be made of record therein and appear among
the "References Cited" on any patent to issue therefrom.
A copy of the references as cited on the attached Form PTO/SB/08 has not been
provided.
This Information Disclosure Statement is not to be construed as a representation
that: (i) a search has been made; (ii) additional information material to the examination of
this application does not exist; (iii) the information, protocols, results and the like reported
by third parties are accurate or enabling; or (Iv) the cited information is, or Is considered to
V*11 92120 v1
1
Attorney Docket No. 12080027.000019
be, material to patentability. In addition, applicant does not admit that any enclosed item of
information constitutes prior art to the subject invention and specifically resen/es the right
to demonstrate that any such reference is not prior art.
It is submitted that the Information Disclosure Statement is in compliance with 37
CFR 1.97(b)(3) and the Examiner is respectfully requested to consider the listed
references.
This Information Disclosure Statement is filed after the mailing date of a Final Office
Action or Notice of Allowance, whichever occurred first, but on or before payment of the
Issue Fee (37 CFR 1.97(d)). Applicant hereby petitions that the information Disclosure
Statement be considered.
! hereby certify, pursuant to 37 CFR 1 .97(e)(2), that no item of information contained
in this Information Disclosure Statement was cited in a communication from a foreign
patent office in a counterpart foreign application and, to my knowledge after making
reasonable inquiry, no item of information contained in this Infonnation Disclosure
Statement was known to any individual designated in 37 CFR 1.56(c) more than three
months prior to the filing of this Information Disclosure Statement
Our check in the amount of $180.00 covering the fee set forth in 37 CFR 1 .17{p) is
enclosed.
W119212D v1
2
Attorney Docket No, 12080027,000019
The Director is hereby authorized to charge any deficiency in the fees filed, asserted
to be filed or which should have been filed herewith {or with any paper hereafter filed in this
application by this firm) to our Deposit Account No. 03-1250 {Ret No, 12080027.000019).
Dated: May 23. 2007 Respectfully submitted.
B y /Aasheesh Shravah/
Aasheesh Shravah
Registration No.: 54,445
SILLS CUMMIS EPSTEIN & GROSS, P.C,
One Rockefeller Plaza
New York, NY 10020
(212)643-7000
(212) 643^6500 (Fax)
Attorney for Applicant
\#1 192120 v1
3
PTO/$B/08A (09-06)
Approved for use through 03/31/2)07. OMB 0651-0031
U.S. Patent and Trad^ark Office; U.S. DEPARTMENT OF COMMERCE
Under the PaperwQr1< Reduction Act of 1995. no persons are required to respond to a collecfton of information unless It contains a valid 0MB contfol numbe r.
Substitute for form 1449/PTO
INFORMATION DISCLOSURE
STATEMENT BY APPLICANT
(Use as many sheets as necessary)
Complete if Known
Application Number
Filing Date
First Named Inventor
/^Unit
Examiner Name
10/825,786
4/16/2004
Russell A, Houser
3734
Dowe, Katherine Marie
Attorney Docl^et N limber
12080027.000019
U. S. PATENT DOCUMENTS
1- vam inor
CABlMiriBl
Initials*
Cite
No.'
uocurneni niiMTiOcr
MM-DD-YYYY
Nsme of Patentee or
Applicant Of Cited Document
Pages, Columns, Li?^es, Where
Relevant Passages or Relevant
Figures Appear
Number-Kind Code^^^*™"^'
^^"5,797,960
08/25/1998
Stevens
^^■6,383.896
01/24/1995
Gershony
Ub-
Uo-
i IC
uo-
US-
US^
us-
us-
us-
us-
us-
us-
us-
us-
us-
us-
us-
us-
FORHIGN PATENT DOCUMENTS
Examiner
Initials*
Cite
Foreign Patent Document
Publication
Date
MM-DD-YYYY
Name of Patentee or
/applicant of Cited Document
Pages, Corumns, lines.
Where Relevant Passages
Or RgJevant Figures Appear
Country Code^* "Number * "Kind CodQ^ (if known)
^ Examiner
Signature
Date
Considered
considered. Include copy of this form with next communication to applicant ^Api^icant's unique citation designatiof^ number (optional. ^See Kinds Codes of
USPTO Patent Documents at vww.uspto.gov or MPEP 901.04. ^ Er^ter Office that issued the document, by the two-letter code (WJPO Star^d^ird ST.3). ^ For
Japanese patent documents, the indication of the year of the reigrj of the Emperor must precede the serial rtumber of the patent document. ^Kind of document by
the appropriate symbols as indicated on the document under WlPO Standard ST.16 if possible. ^Appiicam is to place ^ check mark here if English language
Translation is attached.
This collection of mformation is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a beriefit by the public which is to file (and by the
USPTO to process) an applicabon. Confidemiaiity is governed by 36 U.S.C. 122 and 37 CFR 1.14. This c<^)ectEon is estimated to take 2 hours to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments
on the amount of time you require to complete this fomi anchor suggestions for radudng this burden, should be sent to the Chief information Officer, U.S. Patem
and Trademark Office, P.O. Box 1450, Alexandria. VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND
TO: Commls{»loner tor P«tettt», P.O. Box 1450, Alexandria, VA 22313^1450.
if you need assistance in completing the form, caH 1'B0O'PTO''9199 (1-800-786-9199) and setecf option 2.